MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*2022: 100 largest medtech companies
Artivion, Inc. (NYSE: AORT), formerly CryoLife*
Organization & Developments: Artivion
Parents
Artivion, Inc. (NYSE: AORT), formerly CryoLife*
Children
*Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive
*Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices.
2023: Artivion Stock: A First Assessment_ seekingalpha.com
2023: Artivion’s Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025 (AORT)
2024: Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
2024: Artivion: Current Valuation Seems Stretched
2024: US medical device giant Artivion says hackers stole files during cybersecurity incident
2026: Artivion closes $175M acquisition of aortic arch maker Endospan
Jumps
Finance & Acquisition: Artivion
Key People: Artivion